Efficacy and safety of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel pamoate, and albendazole plus oxantel pamoate against hookworm and concomitant soil-transmitted helminth infections in Tanzania and Côte d'Ivoire: a randomised, controlled, single-blinded, non-inferiority trial

The Lancet Infectious Diseases

Volumn 17, Issue 11, 2017, Pages 1162-1171

  Moser, Wendelin ^a   Coulibaly, Jean T ^a,c   Ali, Said M ^b   Ame, Shaali M ^b   Amour, Amour K ^b   Yapi, Richard B ^c   Albonico, Marco ^d   Puchkov, Maxim ^a   Huwyler, Jörg ^a   Hattendorf, Jan ^a   Keiser, Jennifer ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Public Health Laboratory Ivo De Carneri   (Tanzania)

^c CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; IVERMECTIN; OXANTEL EMBONATE; PLACEBO; TRIBENDIMIDINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASCARIS LUMBRICOIDES; CLINICAL OUTCOME; CONTROLLED STUDY; COTE D'IVOIRE; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FECES; FEMALE; FOLLOW UP; HEADACHE; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON-INFERIORITY TRIAL; NONHUMAN; PARASITE EGG COUNT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SOIL; SYMPTOMATOLOGY; TANZANIA; TRICHURIS TRICHIURA; VERTIGO; VOMITING; ANIMAL; ASCARIASIS; COINFECTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOOKWORM INFECTIONS; ORAL DRUG ADMINISTRATION; PARASITOLOGY; TREATMENT OUTCOME; TRICHURIASIS;

ADMINISTRATION, ORAL; ADOLESCENT; ANIMALS; ANTHELMINTICS; ASCARIASIS; COINFECTION; COTE D'IVOIRE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FECES; HOOKWORM INFECTIONS; HUMANS; PARASITE EGG COUNT; PLACEBOS; SINGLE-BLIND METHOD; TANZANIA; TREATMENT OUTCOME; TRICHURIASIS;

EID: 85028524637     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30487-5     Document Type: Article

References (29)

1. Pullan, RL, Smith, JL, Jasrasaria, R, Brooker, SJ, Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasit Vectors, 7, 2014, 37.
2. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1603–1658.
3. WHO. Soil-transmitted helminthiasis: eliminating soil-transmitted helminthiasis as a public health problem in children. Progress report 2001–10 and strategic plan 2011–20, 2012, World Health Organization, Geneva.
4. WHO. Update on the global status of implementation of preventive chemotherapy, 2017, World Health Organization, Geneva.
5. Keiser, J, Utzinger, J, Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 299 (2008), 1937–1948.
6. Diawara, A, Halpenny, CM, Churcher, TS, et al. Association between response to albendazole treatment and β-tubulin genotype frequencies in soil-transmitted helminths. PLoS Negl Trop Dis, 7, 2013, e2247.
7. PATH, Clarus, and the Global Health Investment Fund announce an innovative $25 million financing arrangement to improve treatment of intestinal worms, affecting more than 1 billion people worldwide. http://www.path.org/news/press-room/797/ (accessed Feb 27, 2017).
8. Robertson, AP, Puttachary, S, Buxton, SK, Martin, RJ, Tribendimidine: mode of action and nAchr subtype selectivity in ascaris and oesophagostomum. PLoS Negl Trop Dis, 9, 2015, e0003495.
9. Xiao, SH, Utzinger, J, Tanner, M, Keiser, J, Xue, J, Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations. Acta Trop 126 (2013), 115–126.
10. Alles, R, Puchkov, M, Jablonski, C, Speich, B, Keiser, J, Huwyler, J, Development of oxantel tablets for pediatric clinical studies: a technical note. J Drug Deliv Sci Technol 23 (2013), 623–625.
11. Katz, N, Chaves, A, Pellegrino, J, A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop São Paulo 14 (1972), 397–400.
12. Martin, LK, Beaver, PC, Evaluation of Kato thick-smear technique for quantitative diagnosis of helminth infections. Am J Trop Med Hyg 17 (1968), 382–391.
13. Speich, B, Ali, SM, Ame, SM, Albonico, M, Utzinger, J, Keiser, J, Quality control in the diagnosis of Trichuris trichiura and Ascaris lumbricoides using the Kato-Katz technique: experience from three randomised controlled trials. Parasit Vectors, 8, 2015, 82.
14. Knopp, S, Mohammed, KA, Speich, B, et al. Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial. Clin Infect Dis 51 (2010), 1420–1428.
15. Speich, B, Ame, SM, Ali, SM, et al. Oxantel pamoate–albendazole for Trichuris trichiura infection. N Engl J Med 370 (2014), 610–620.
16. Moser, W, Ali, SM, Ame, SM, et al. Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study. Lancet Infect Dis 16 (2016), 53–60.
17. Speich, B, Ali, SM, Ame, SM, et al. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial. Lancet Infect Dis 15 (2015), 277–284.
18. Coulibaly, JT, Fürst, T, Silué KD, et al. Intestinal parasitic infections in schoolchildren in different settings of Côte d'Ivoire: effect of diagnostic approach and implications for control. Parasit Vectors, 5, 2012, 135.
19. WHO. Assessing the efficacy of anthelminthic drugs against schistosomiasis and soil-transmitted helminthiases, 2013, World Health Organzation, Geneva.
20. Efron, B, The bootstrap and Markov-chain Monte Carlo. J Biopharm Stat 21 (2011), 1052–1062.
21. Wu, Z, Fang, Y, Liu, Y, Effect of a novel drug–enteric coated tribendimidine in the treatment of intestinal nematode infections. Chin J Parasitol Parasit Dis 24 (2006), 23–26.
22. Steinmann, P, Zhou, X-N, Du, Z-W, et al. Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis, and Taenia spp: open-label randomized trial. PLoS Negl Trop Dis, 2, 2008, e322.
23. Wen, LY, Yan, XL, Sun, FH, Fang, YY, Yang, MJ, Lou, LJ, A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China. Acta Trop 106 (2008), 190–194.
24. Wu, Z, Qian, Y, Therapeutic effect of tribendimidine combined with ivermectin against human intestinal nematode infection. Chinese J Pract Par Dis 2 (2003), 59–61.
25. Levecke, B, Mekonnen, Z, Albonico, M, Vercruysse, J, The impact of baseline faecal egg counts on the efficacy of single-dose albendazole against Trichuris trichiura. Trans R Soc Trop Med Hyg 106 (2012), 128–130.
26. Nikolay, B, Brooker, SJ, Pullan, RL, Sensitivity of diagnostic tests for human soil-transmitted helminth infections: a meta-analysis in the absence of a true gold standard. Int J Parasitol 44 (2014), 765–774.
27. Cowan, N, Vargas, M, Keiser, J, In vitro and in vivo drug interaction study of two lead combinations, oxantel pamoate plus albendazole and albendazole plus mebendazole, for the treatment of soil-transmitted helminthiasis. Antimicrob Agents Chemother 60 (2016), 6127–6133.
28. Soukhathammavong, P, Odermatt, P, Sayasone, S, et al. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis 11 (2011), 110–118.
29. Barda, B, Coulibaly, JT, Puchkov, M, Huwyler, J, Hattendorf, J, Keiser, J, Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against Schistosoma haematobium and S mansoni infections: a randomized, exploratory phase 2 trial. PLoS Negl Trop Dis, 10, 2016, e0005008.